News Agency
Men's Weekly

GenScript Biotech Announces 2023 Annual Results with a Five-Year CAGR stands at 30%

  • Written by PR Newswire

R&D Innovation to Lead the Future, Deepening Customer Value Creation

  • Sustained High Revenue Growth: GenScript Group's five-year CAGR stands at an impressive 30%, with a strong global operation and stable cash flow. In 2023, the group's best-in-class cell therapy product CARVYKTI®, achieved sales exceeding $500 million, becoming the...

Read more: GenScript Biotech Announces 2023 Annual Results with a Five-Year CAGR stands at 30%

Understanding Your Rights Around Property After Separation

Property division is one of the most significant financial matters that arises when a relationship ends, and it's also one of the most commonly misunderstood. Many people assume that assets are simply divided equally, but the reality under Australian family... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion